Why did INO stock move up on 2026-11-02?
In plain English
Precigen Gears Up to Report Q3 Earnings: What Can Investors Expect? — Zacks Investment Research.
What it means for you
Spiked then faded — most of the early gain was given back by the close. Risk level: high.
Where this comes from
Observed market data. The price, percentage move, open, close and volume above are end-of-day figures for 2026-11-02 from XNAS, not estimates.
Sourced news. Articles published around 2026-11-02 that mention INO. We link them so you can read the original — we do not summarise them into a cause:
- Precigen Gears Up to Report Q3 Earnings: What Can Investors Expect? — Zacks Investment Research (2026-11-02)
- FDA Backs PFE's Tukysa Combo in Front-Line Maintenance Breast Cancer — Zacks Investment Research (2026-10-08)
- PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? — Zacks Investment Research (2026-09-30)
About Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own dis
INO — frequently asked
Why did INO stock move up on 2026-11-02?
Precigen Gears Up to Report Q3 Earnings: What Can Investors Expect? — Zacks Investment Research. Spiked then faded — most of the early gain was given back by the close.
See it in context
INO opened +230.3% versus the prior close, then finished -5.0% from its open, on 222.3M shares traded.
Against the whole market that day, 48.4% of US stocks closed higher (median move +0.0%) — so INO moved in a mixed market. See the full market recap →
More movers: today's biggest gainers · today's biggest gap-ups · all screeners · why other stocks are moving
Learn the basics: how to read a chart · what volume means · grade INO’s chart with the AI reader →